215 related articles for article (PubMed ID: 12022908)
1. Therapeutic equivalency of low-molecular-weight heparins.
McCart GM; Kayser SR
Ann Pharmacother; 2002 Jun; 36(6):1042-57. PubMed ID: 12022908
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparins in the treatment of deep-vein thrombosis.
Martineau P; Tawil N
Ann Pharmacother; 1998 May; 32(5):588-98, 601. PubMed ID: 9606481
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism.
Ornstein DL; Hong-Dice YG; Papini JR
Mil Med; 2001 Jul; 166(7):593-601. PubMed ID: 11469031
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients.
Deitelzweig SB; Vanscoy GJ; Niccolai CS; Rihn TL
Ann Pharmacother; 2003 Mar; 37(3):402-11. PubMed ID: 12639173
[TBL] [Abstract][Full Text] [Related]
5. The low molecular weight heparin, tinzaparin, in thrombosis and beyond.
Mousa SA
Cardiovasc Drug Rev; 2002; 20(3):199-216. PubMed ID: 12397367
[TBL] [Abstract][Full Text] [Related]
6. Safety profile of different low-molecular weight heparins used at therapeutic dose.
Gouin-Thibault I; Pautas E; Siguret V
Drug Saf; 2005; 28(4):333-49. PubMed ID: 15783242
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparins for acute coronary syndromes.
Spinler SA; Nawarskas JJ
Ann Pharmacother; 1998 Jan; 32(1):103-10. PubMed ID: 9475828
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings.
Nutescu EA; Spinler SA; Wittkowsky A; Dager WE
Ann Pharmacother; 2009 Jun; 43(6):1064-83. PubMed ID: 19458109
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular-weight heparins in the management of unstable angina.
Agnelli G; Sonaglia F
Haemostasis; 2000; 30 Suppl 2():158-67; discussion 146-7. PubMed ID: 11251362
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparins and unstable angina--current perspectives.
Turpie AG
Haemostasis; 1997; 27 Suppl 1():19-24. PubMed ID: 9439754
[TBL] [Abstract][Full Text] [Related]
11. Differences among low-molecular-weight heparins: evidence in patients with acute coronary syndromes.
Nicolau JC; Cohen M; Montalescot G
J Cardiovasc Pharmacol; 2009 Jun; 53(6):440-5. PubMed ID: 19365279
[TBL] [Abstract][Full Text] [Related]
12. Evolving role of low-molecular-weight heparins in ST-elevation myocardial infarction.
Kalus JS; Moser LR
Ann Pharmacother; 2005 Mar; 39(3):481-91. PubMed ID: 15701782
[TBL] [Abstract][Full Text] [Related]
13. New-generation anticoagulants: the low molecular weight heparins.
Hovanessian HC
Ann Emerg Med; 1999 Dec; 34(6):768-79. PubMed ID: 10577408
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
De Luca G; Marino P
Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparins are essentially the same for treatment and prevention of venous thromboembolism.
Lopez LM
Pharmacotherapy; 2001 Jun; 21(6 Pt 2):56S-61S; discussion 71S-72S. PubMed ID: 11401194
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparins in acute unstable coronary artery disease - an update.
Turpie AG
Haemostasis; 1999 Dec; 29 Suppl S1():72-5. PubMed ID: 10629408
[TBL] [Abstract][Full Text] [Related]
17. [Prospective randomized study comparing the effectiveness and tolerance of various low-molecular-weight heparins in high risk patients].
Janni W; Bergauer F; Rjosk D; Lohscheidt K; Hagena FW
Zentralbl Chir; 2001 Jan; 126(1):32-8. PubMed ID: 11227291
[TBL] [Abstract][Full Text] [Related]
18. Use of anticoagulants in ST-segment elevation myocardial infarction patients; a focus on low-molecular-weight heparin.
Gurm HS; Eagle KA
Cardiovasc Drugs Ther; 2008 Feb; 22(1):59-69. PubMed ID: 18165932
[TBL] [Abstract][Full Text] [Related]
19. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice].
Ottani F; Ferrini D; Di Pasquale G; Galvani M
Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833
[TBL] [Abstract][Full Text] [Related]
20. Low-molecular-weight heparins in conjunction with thrombolysis for ST-elevation acute myocardial infarction. A critical review of the literature.
Rubboli A; Ottani F; Capecchi A; Brancaleoni R; Galvani M; Swahn E
Cardiology; 2007; 107(2):132-9. PubMed ID: 16864962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
